Detalles de la búsqueda
1.
Impact of High-Level Daptomycin Resistance in the Streptococcus mitis Group on Virulence and Survivability during Daptomycin Treatment in Experimental Infective Endocarditis.
Antimicrob Agents Chemother;
61(5)2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28264848
2.
Early in vitro development of daptomycin non-susceptibility in high-level aminoglycoside-resistant Enterococcus faecalis predicts the efficacy of the combination of high-dose daptomycin plus ampicillin in an in vivo model of experimental endocarditis.
J Antimicrob Chemother;
72(6): 1714-1722, 2017 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28204495
3.
Fosfomycin plus ß-Lactams as Synergistic Bactericidal Combinations for Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus.
Antimicrob Agents Chemother;
60(1): 478-86, 2016 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26525803
4.
Daptomycin is effective for treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus epidermidis.
Antimicrob Agents Chemother;
54(7): 2781-6, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20421394
5.
Addition of gentamicin or rifampin does not enhance the effectiveness of daptomycin in treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
Antimicrob Agents Chemother;
53(10): 4172-7, 2009 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-19620326
6.
Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone.
Clin Microbiol Infect;
20(12): O1075-83, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25040215
Resultados
1 -
6
de 6
1
Próxima >
>>